Cognetivity Neurosciences Ltd. Share Price
Stocks
CGNSF
CA19243C1005
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000001 USD | -99.00% |
|
-.--% | - |
| Market Cap | 11.99L 8L 7L 7L 6L 8.03Cr 12.17L 81.39L 31.64L 3.95Cr 31.68L 31L 14Cr | P/E 2022 |
-2.9x | P/E 2023 | -2.8x |
|---|---|---|---|---|---|
| Enterprise Value | 2L 2L 2L 1L 1L 1.64Cr 2L 16.65L 6L 80.79L 6L 6L 2.78Cr | EV / Sales 2022 |
-
| EV / Sales 2023 | 43,79,22,999x |
| Free-Float |
85.56% | Yield 2022 * |
-
| Yield 2023 | - |
| 1 day | -99.00% |
| Current year | 0 | 0 | |
| 1 year | 0 | 0 | |
| 3 years | 0 | 0.2 | |
| 5 years | 0 | 0.87 | |
| 10 years | 0 | 1.12 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sina Habibi
CEO | Chief Executive Officer | 45 | 01/04/2013 |
Mark Phillips
CMP | Compliance Officer | 67 | 21/12/2017 |
| Director | Title | Age | Since |
|---|---|---|---|
Sina Habibi
BRD | Director/Board Member | 45 | 01/01/2017 |
Mark Phillips
BRD | Director/Board Member | 67 | 21/12/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 15/24/15 | Option | Founder | 6,00,000 | 0.6697% | ||
| 15/24/15 | Option | Founder | 6,00,000 | 0.6697% | ||
| 23/23/23 | Sell | Founder | 11,08,160 | 1.3030% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -99.00% | -.--% | - | - | 93 | ||
| +4.62% | +12.48% | -32.20% | -3.04% | 3.13TCr | ||
| +1.97% | +8.27% | -31.04% | +233.65% | 1.52TCr | ||
| -0.88% | +7.42% | -16.78% | +65.59% | 590.9Cr | ||
| -8.94% | -21.56% | - | - | 241.17Cr | ||
| +5.52% | +5.71% | - | - | 223.18Cr | ||
| +2.62% | +7.23% | +44.20% | -40.57% | 195.7Cr | ||
| -3.11% | -15.09% | -30.20% | - | 114.12Cr | ||
| -1.25% | +6.04% | -33.57% | +271.06% | 83Cr | ||
| -1.21% | +0.62% | +552.00% | +1,064.29% | 76Cr | ||
| Average | -9.97% | +4.41% | +64.63% | +265.16% | 617.32Cr | |
| Weighted average by Cap. | +2.59% | +14.39% | -19.92% | +85.63% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | - | 0.05 0.03 0.03 0.03 0.02 3.04 0.05 0.31 0.12 1.49 0.12 0.12 5.15 |
| Net income | -1.31Cr -92.42L -80.8L -74.25L -69.21L -88Cr -1.33Cr -8.91Cr -3.47Cr -43Cr -3.47Cr -3.39Cr -149.06Cr | -74.34L -52.34L -45.75L -42.05L -39.19L -50Cr -75.47L -5.05Cr -1.96Cr -24Cr -1.96Cr -1.92Cr -84Cr |
| Net Debt | -82.43T -58.04T -50.73T -46.62T -43.46T -55.26L -83.68T -6L -2L -27.16L -2L -2L -93.6L | -10L -7L -6L -5L -5L -6.39Cr -10L -64.74L -25.17L -3.14Cr -25.2L -24.66L -11Cr |
Employees
-
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CGNSF Stock
Select your edition
All financial news and data tailored to specific country editions
















